Published in Proc Natl Acad Sci U S A on July 01, 1982
Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. Nucleic Acids Res (1984) 8.36
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res (1985) 3.69
Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58
Processing the nonstructural polyproteins of sindbis virus: nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans. J Virol (1989) 3.30
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
A second protease of foot-and-mouth disease virus. J Virol (1986) 2.87
Small nuclear inclusion protein encoded by a plant potyvirus genome is a protease. J Virol (1987) 2.77
In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase. Nucleic Acids Res (1987) 2.77
Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region. J Virol (1986) 2.72
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus. J Virol (1993) 2.38
Protein processing map of poliovirus. J Virol (1984) 2.33
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Host range mutants of human rhinovirus in which nonstructural proteins are altered. J Virol (1983) 2.19
Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis. J Virol (2000) 2.16
Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13
Purification and properties of poliovirus RNA polymerase expressed in Escherichia coli. J Virol (1989) 2.00
Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited. Proc Natl Acad Sci U S A (1989) 2.00
Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res (1986) 1.96
Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5' noncoding region. J Virol (1990) 1.96
Biochemical and mutational analysis of a plant virus polyprotein cleavage site. EMBO J (1988) 1.91
Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J Virol (1991) 1.84
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.76
Site-directed mutagenesis of proteinase 3C results in a poliovirus deficient in synthesis of viral RNA polymerase. J Virol (1987) 1.75
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J Virol (1990) 1.69
Polyprotein processing of Theiler's murine encephalomyelitis virus. J Virol (1989) 1.64
Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J Virol (1987) 1.61
Association of poliovirus proteins with the endoplasmic reticulum. J Virol (1984) 1.57
Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1. J Virol (1989) 1.54
Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48
Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex. Proc Natl Acad Sci U S A (1985) 1.47
Biochemical map of polypeptides specified by foot-and-mouth disease virus. J Virol (1984) 1.46
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Res (1983) 1.43
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol (1989) 1.38
Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme. J Virol (1989) 1.38
Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase. J Virol (1991) 1.37
Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol. J Virol (1995) 1.37
Evidence That the 32,000-Dalton Protein Encoded by Bottom-Component RNA of Cowpea Mosaic Virus is a Proteolytic Processing Enzyme. J Virol (1984) 1.36
Evolutionary relationships within the human rhinovirus genus: comparison of serotypes 89, 2, and 14. Proc Natl Acad Sci U S A (1987) 1.31
Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation. Proc Natl Acad Sci U S A (1989) 1.30
Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J Virol (1991) 1.26
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol (1992) 1.25
Expression of enzymatically active poliovirus RNA-dependent RNA polymerase in Escherichia coli. Proc Natl Acad Sci U S A (1987) 1.24
Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J Virol (1993) 1.24
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Multiple proteases in foot-and-mouth disease virus replication. J Virol (1984) 1.18
Infection of HeLa cells with poliovirus results in modification of a complex that binds to the rRNA promoter. J Virol (1992) 1.18
Poliovirus protease 3C (P3-7c) does not cleave P220 of the eucaryotic mRNA cap-binding protein complex. J Virol (1985) 1.18
Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. J Virol (1993) 1.18
Cowpea mosaic virus VPg: sequencing of radiochemically modified protein allows mapping of the gene on B RNA. EMBO J (1984) 1.16
Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.16
Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity. J Virol (1989) 1.15
Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors. J Virol (1987) 1.15
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. J Virol (1993) 1.15
Purification and partial characterization of poliovirus protease 2A by means of a functional assay. J Virol (1988) 1.13
Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA (1998) 1.13
Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J Virol (1993) 1.10
A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus. Proc Natl Acad Sci U S A (1991) 1.07
Transduction of a human RNA sequence by poliovirus. J Virol (1994) 1.06
Autocatalytic processing of the potyvirus helper component proteinase in Escherichia coli and in vitro. J Virol (1989) 1.05
Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J Virol (1999) 1.05
Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase. J Virol (2006) 1.03
RNA binding properties of poliovirus subviral particles. J Virol (1995) 1.02
Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions. J Virol (1995) 1.01
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A. J Virol (1990) 1.00
Picornavirus modification of a host mRNA decay protein. MBio (2012) 0.98
A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation. J Virol (1990) 0.96
Epidemics to eradication: the modern history of poliomyelitis. Virol J (2007) 0.96
A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor. J Virol (1993) 0.95
Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor. J Virol (2005) 0.95
Cleavage of a viral polyprotein by a cellular proteolytic activity. J Virol (1986) 0.94
Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis. J Virol (2012) 0.90
cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. J Virol (1991) 0.90
Adenovirus type 2 endopeptidase: an unusual phosphoprotein enzyme matured by autocatalysis. Proc Natl Acad Sci U S A (1987) 0.87
Mutagenesis of the coxsackie B3 virus 2B/2C cleavage site: determinants of processing efficiency and effects on viral replication. J Virol (1996) 0.84
Heterogeneous Nuclear Ribonucleoprotein M Facilitates Enterovirus Infection. J Virol (2015) 0.82
Differential rescue of poliovirus RNA replication functions by genetically modified RNA polymerase precursors. J Virol (2004) 0.82
Intratypic recombination of polioviruses: evidence for multiple crossing-over sites on the viral genome. J Virol (1987) 0.81
Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation. J Virol (1993) 0.81
Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. J Gen Virol (2013) 0.80
An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases. J Virol (2006) 0.80
Proteinase trapping: screening for viral proteinase mutants by alpha complementation. Proc Natl Acad Sci U S A (1991) 0.79
Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract. J Virol (2011) 0.78
Human rhinovirus 2A proteinase mutant and its second-site revertants. Biochem J (1996) 0.78
Toward an in vitro system for picornavirus assembly: purification of mengovirus 14S capsid precursor particles. J Virol (1986) 0.76
Detection of a Novel Protein Encoded by the Bottom-Component RNA of Cowpea Mosaic Virus, Using Antibodies Raised against a Synthetic Peptide. J Virol (1987) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A (1977) 40.24
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Polypeptide cleavages in the formation of poliovirus proteins. Proc Natl Acad Sci U S A (1968) 10.43
Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24
Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci U S A (1979) 6.93
Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci U S A (1968) 5.64
Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme. Eur J Biochem (1978) 4.16
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing. J Virol (1979) 3.64
Cell-free synthesis and processing of the proteins of poliovirus. Proc Natl Acad Sci U S A (1978) 3.39
A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07
Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03
5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00
Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91
Immunoautoradiographic detection of proteins after electrophoretic transfer from gels to diazo-paper: analysis of adenovirus encoded proteins. Proc Natl Acad Sci U S A (1981) 2.88
Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58
Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites. J Virol (1982) 2.11
Cleavage sites in the polypeptide precursors of poliovirus protein P2-X. Virology (1981) 2.04
Cleavage sites within the poliovirus capsid protein precursors. J Virol (1982) 1.95
The fate of VPg during in vitro translation of poliovirus RNA. FEBS Lett (1981) 1.74
Structure and expression of the picornavirus genome. Ann N Y Acad Sci (1980) 1.58
Virus-specified protease in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1979) 1.42
Amino-terminal sequence of adenovirus type 2 proteins: hexon, fiber, component IX, and early protein 1B-15K. Virology (1980) 1.39
Encephalomyocarditis virus-specific polypeptide p22 is involved in the processing of the viral precursor polypeptides. FEBS Lett (1979) 1.39
Structure of the Mengo virion. IV. Amino- and carboxyl-terminal analyses of the major capsid polypeptides. Virology (1976) 1.25
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52
Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev (1998) 7.78
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01
Viral proteinases. Annu Rev Biochem (1988) 6.76
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
The separation of soluble ribonucleic acids on benzoylated diethylaminoethylcellulose. Biochemistry (1967) 6.04
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell (1988) 5.49
Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem (2001) 5.43
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
Cell-free, de novo synthesis of poliovirus. Science (1991) 5.09
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A (1993) 4.71
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell (1995) 4.64
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology (1988) 4.53
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Proc Natl Acad Sci U S A (1975) 4.35
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
Identification of the SV40 agnogene product: a DNA binding protein. Nature (1981) 3.80
Defective interfering particles of poliovirus. I. Isolation and physical properties. J Virol (1971) 3.74
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol (1992) 3.68
Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature (1998) 3.64
Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62
Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58
Location and identification of the genes for adenovirus type 2 early polypeptides. Cell (1976) 3.58
Cell-free synthesis of adenovirus 2 proteins programmed by fractionated messenger RNA: a comparison of polypeptide products and messenger RNA lengths. Proc Natl Acad Sci U S A (1974) 3.52
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47
Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J (1999) 3.46
Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J Biol Chem (1994) 3.45
Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40
Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J Virol (1984) 3.38
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature (1983) 3.35
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol (1990) 3.30
Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology (1983) 3.28
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol (1986) 3.15
Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol (2000) 3.14
A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Genome-linked proteins of viruses. Cell (1982) 3.02
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91
Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J Virol (1991) 2.86
Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82
Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A (1996) 2.78
Further mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Cell (1977) 2.78
In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase. Nucleic Acids Res (1987) 2.77
Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A (1996) 2.71
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol (1982) 2.63
Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem (1995) 2.62
Sequence studies of poliovirus RNA. I. Characterization of the 5'-terminus. J Mol Biol (1972) 2.56
DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes Dev (1992) 2.56
Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme (1990) 2.51
Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J Virol (1995) 2.47
Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis. J Virol (1991) 2.44
Preparation of a cell-free protein-synthesizing system from wheat germ. Methods Enzymol (1983) 2.43
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded. J Virol (1975) 2.42
Normal tRNAs promote ribosomal frameshifting. Cell (1979) 2.41
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA. J Virol (1981) 2.40
p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J (2000) 2.38
Identification and characterization of an immunologically conserved adenovirus early region 11,000 Mr protein and its association with the nuclear matrix. J Mol Biol (1982) 2.36
Pattern of protein synthesis in monkey cells infected by simian virus 40. J Virol (1972) 2.35
Protein processing map of poliovirus. J Virol (1984) 2.33